Lipoprotein abnormalities in hemodialysis and continuous ambulatory peritoneal dialysis patients

Renal Failure

Volumn 24, Issue 5, 2002, Pages 623-630

  Fytili, Christina I ^a   Progia, Euaggelia G ^a   Panagoutsos, Stelios A ^b   Thodis, Elias D ^b   Passadakis, Ploumis S ^b   Sombolos, Kostas I ^a   Vargemezis, Vassilis A ^b  

^a G H 'G Papa nikolaou'   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Apolipoproteins; CAPD; Hemodialysis; Lipid parameters; Lp(a)

Indexed keywords

ALBUMIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN B; APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

AGED; APOLIPOPROTEINS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; HYPERLIPIDEMIAS; KIDNEY FAILURE, CHRONIC; LIPOPROTEINS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; RENAL DIALYSIS; SERUM ALBUMIN; TRIGLYCERIDES;

EID: 0036382881     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-120013966     Document Type: Article

References (16)

1. Attman, P.O.; Alaupovic, P.; Gustafson, A. Serum Apolipoprotein Profile of Patients with Chronic Renal Failure. Kidney Int. 1987, 32, 368-375.
2. Senti, M.; Romero, R.; Pedro-Botet, J. et al. Lipoprotein Abnormalities in Hyperlipidemic and Normolipidemic Men on Hemodialysis with Chronic Renal Failure. Kidney Int. 1992, 41, 1394-1399.
3. Lacout, B.; Roullet, J.; Beyne, P. et al. Comparisons of Several Atherogenicity Indices by the Analysis of Serum Lipoprotein Composition in Patients with Chronic Renal Failure with or without Hemodialysis, and in Renal Transplant Patients. J. Clin. Chem. Clin. Biochem. 1985, 23, 805-810.
4. Assmann, G.; Schulte, H.; von Eckardstein, A. Hypertriglyceridemia and Elevated Lipoprotein(a) are Risks Factors for Major Coronary Events in Middle-Aged Men. Am. J. Cardiol. 1996, 77, 1179-1184.
5. Dahlen, G.H. Lp(a) Lipoprotein in Cardiovascular Diseases. Atherosclerosis 1994, 108, 111-126.
6. Raitakari, O.T.; Adams, M.R.; Celermajer, D.S. Effect of Lp(a) on the Early Functional and Structural Changes of Atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 1999, 19(4), 900-905.
7. National Cholesterol Education Program: Adult Treatment Panel II Report, Special Communication. JAMA 1993, 269, 3015-3025.
8. Cressman, M.D.; Heyka, R.J.; Paganini, E.P.; O'Neil, J.; Skibinski, C.I.; Hoff, H.F. Lipoprotein (a) is an Independent Risk Factor for Cardiovascular Disease in Hemodialysis Patients. Circulation 1992, 86, 475-482.
9. Ochoa-Sosa, C.A.; Mondragon-Rodriguez, G.; Zamora-Gonzalez, J. et al. Lipoprotein (a) and Lipids in Chronic Renal Insufficiency. Rev. Invest. Clin. 1999, 50(4), 301-306.
10. Cobbaert, C.; Jukema, J.W.; Zwinderman, A.H. et al. on Behalf of the Regression Growth Evaluation Statin Study (REGRESS) Study Group. Modulation of Lp(a) Atherogenicity by High Density Lipoprotein Cholesterol Levels in Middle-Aged Men with Symptomatic Coronary Artery Disease and Normal to Moderately Elevated Serum Cholesterol. J. Am. Coll. Cardiol. 1997, 30, 1491.
11. Tanaka, S. Alterations of Serum Lipoprotein (a) Levels in Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients. Nippon. Jinzo. Gakkai. Shi. 1994, 36(6), 746-751.
12. Heimburger, O.; Stenvinkel, P.; Berglund, L. et al. Increased Plasma Lipoprotein (a) in Continuous Ambulatory Peritoneal Dialysis is Related to Peritoneal Transport of Proteins and Glucose. Nephron 1996, 72, 135-144.
13. Ross, E.A.; Shah, G.M.; Kashyap, M.L. Elevated Plasma Lipoprotein (a) Levels and Hypoalbuminemia in Peritoneal Dialysis Patients. Int. J. Art. Organs 1995, 18(12), 751-756.
14. Ohashi, H.; Oda, H.; Ohno, M. et al. Lipoprotein(a) as a Risk Factor for Coronary Artery Disease in Hemodialysis Patients. Kidney Int. 1999, 56(71), 242-244.
15. Koda, Y.; Nishi, S.; Suzuki, M. et al. Lipoprotein(a) is a Predictor for Cardiovascular Mortality of Hemodialysis Patients. Kidney Int. 1999, 56(71), 251-253.
16. Kandoussi, A.M.; Hugue, V.; Parra, H.J. et al. Apolipoprotein AI and Apolipoprotein B Containing Particle Analysis in Normolipidemic Hemodialyzed Patients: Evidence of Free Apolipoprotein E. Am. J. Nephrol. 1996, 16(4), 287-292.